Requirement for cystatin C testing in chronic kidney disease: a retrospective population-based study
Creatinine-based estimated glomerular filtration rate (eGFR) determines chronic kidney disease (CKD) stage, but underestimates renal function. The 2014 updated guidance from the National Institute for Health and Care Excellence (NICE) recommends that GPs reduce overdiagnosis of CKD stage 3a (eGFR 45...
主要な著者: | Lasserson, D, Shine, B, O'Callaghan, C, James, T |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Royal College of General Practitioners
2017
|
類似資料
-
Chronic kidney disease: a large-scale population-based study of the effects of introducing the CKD-EPI formula for eGFR reporting
著者:: O'Callaghan, C, 等
出版事項: (2011) -
Cystatin C proteoforms in chronic kidney disease.
著者:: Helene Dahl, 等
出版事項: (2023-01-01) -
Cystatin C proteoforms in chronic kidney disease
著者:: Helene Dahl, 等
出版事項: (2023-01-01) -
Chronic kidney disease--assessing the impact.
著者:: O'Callaghan, C
出版事項: (2009) -
Cystatin C, Vitamin D and Thyroid Function Test Profile in Chronic Kidney Disease Patients
著者:: Marlene Tapper, 等
出版事項: (2021-01-01)